Drug Topics

MARCH 10, 2023

Critics of PBM's say that the high number of exclusions narrows patient options and make medications financially inaccessible.

187

187

STAT

MARCH 10, 2023

Silicon Valley Bank, which does business with roughly half of the nation’s tech and biotech companies, failed on Friday. Now, as federal regulators step in to clean up SVB’s mess, biotech startups are left wondering: What happens to their money, and who’s going to finance the industry? On Friday morning, the Federal Deposit Insurance Corporation took control of SVB and is presiding over a sale of the firm’s assets to cover clients’ deposits.

Insurance 145

Insurance 145

Drug Topics

MARCH 10, 2023

Pharmacy technicians can play an important role in leadership at the pharmacy.

187

187

European Pharmaceutical Review

MARCH 10, 2023

Today marks the opening the NHS Blood and Transplant (NHSBT)’s new Clinical Biotechnology Centre (CBC) in Bristol. The state-of-the-art facility was part-funded by a £9.43 million Government grant and is designed to expand the UK’s ability to manufacture new gene and cell therapies. The CBC will help the UK grow its cell and gene therapy industry in a rapidly growing international market.” “The CBC will help the UK grow its cell and gene therapy industry in a rapidly growing international

Vaccines 128

Vaccines 128

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MARCH 10, 2023

For graduating medical students hoping to secure a residency training position — and that’s virtually all of them — Match Day is the most anticipated day of the year. The Match is the culmination of medical school, application preparation, interviews, and recruitment events. It’s like a traditional job search but without the room for negotiation since it is based on an algorithm that announces job placement once a year, on the third Friday of March, for all participat

Medical Schools 117

Medical Schools 117

Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. A £9.3 million ($11 million) grant is being used to build the facility in Bristol where therapies for currently incurable diseases, such as some forms of cancer, sickle cell disease, and cystic fibrosis can be manufactured.

Communication 105

Communication 105

Pharmaceutical Technology

MARCH 10, 2023

The US Food and Drug Administration (FDA) has granted approval for Pfizer ’s Zavzpret (zavegepant) for the acute treatment of migraine in adult patients with or without aura. Zavzpret is claimed to be the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray approved to treat migraine. It is a third-generation, selective and structurally unique, small molecule CGRP receptor antagonist and is currently under clinical development with oral and intranasal formulation

FDA 98

FDA 98

The Checkup by Singlecare

MARCH 10, 2023

If you find yourself reaching for a cup of coffee every morning or swigging an energy drink each afternoon, you’re not alone. Caffeine is the world’s most-consumed drug—found in the leaves and fruits of some plants, and a key ingredient in caffeinated beverages like coffee, energy drinks, soft drinks, and black or green tea. It’s also found in energy snacks and some non-prescription drugs.

Packaging 98

Packaging 98

Hospital Pharmacy Europe

MARCH 10, 2023

Antioxidant and anti-inflammatory therapy given to sepsis survivors led to worse cognitive and psychological scores after 6 months The provision of antioxidant and anti-inflammatory treatment for sepsis survivors gave rise to lower cognitive and psychological scores compared to placebo after 6 months, according to a randomised trial by the VICTAS investigators.

Hospitals 98

Hospitals 98

Drug Store News

MARCH 10, 2023

Sunscreen and skin protection products saw a surge in retail sales from 2021 to 2022, and the market is expected to grow by 7% in the next year, according to a new survey from Mintel.

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Topics

MARCH 10, 2023

The drug, called Makena, was intended to stop premature births, but has not been effective in its goal, says the FDA.

FDA 98

FDA 98

Drug Store News

MARCH 10, 2023

An integrated solution combines QuidelOrtho's Sofia 2 fluorescent immunoassay analyzer, an automated small benchtop system, with Workflow Services to create a one-stop solution for pharmacists, the companies said.

97

97

Pharmafile

MARCH 10, 2023

A new state-of-the-art facility named the Clinical Biotechnology Centre (CBC) is opening in Bristol, UK. It cost approximately £10m to build, funded by the UK Government. CBC is aiming to support the UK’s cell and gene therapy (CGT) industry, from manufacturing DNA plasmids and viral vectors which are used to create gene and genetically modified cell therapies, to supporting early phase clinical trials and preclinical work.

Communication 97

Communication 97

Hospital Pharmacy Europe

MARCH 10, 2023

Neoadjuvant pembrolizumab in patients with advanced melanoma provides superior event-free survival compared to adjuvant therapy alone Using neoadjuvant pembrolizumab therapy for patients with stage III or IV resectable melanoma gives greater 2-year event-free survival than adjuvant therapy according to the findings of randomised, phase2 trial by US researchers.

Labelling 96

Labelling Hospitals 96

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Drug Store News

MARCH 10, 2023

Joined by EY, Reckitt and Neurodiversity in the Workplace, discussions covered health equity, sustainability, disability hiring and supply chain resiliency.

98

98

STAT

MARCH 10, 2023

By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products. Two recent studies aimed to quantify how much R&D costs impact a drug’s price, and how much a drug’s effectiveness correlates with its price — factors that might, in theory, help justify a sizable price

93

93

Fierce Pharma

MARCH 10, 2023

FDA calls expert hearing for Intercept’s high-profile NASH application for Ocaliva aliu Fri, 03/10/2023 - 10:49

FDA 112

FDA 112

STAT

MARCH 10, 2023

Ever since the Food and Drug Administration approved osimertinib for some early-stage lung cancer patients to take after surgery, clinicians have debated whether the evidence suggested the drug was worth the cost. The initial results of the phase 3 trial testing the drug were “phenomenal,” said Sandeep Patel, a medical oncologist at the University of California, San Diego.

91

91

Fierce Healthcare

MARCH 10, 2023

Medicaid health plans try to protect members—and profits—during unwinding pminemyer Fri, 03/10/2023 - 13:44

109

109

STAT

MARCH 10, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.   That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

89

89

Fierce Healthcare

MARCH 10, 2023

Feds shut down tech investor Silicon Valley Bank, major investor in health tech, biotech companies fdiamond Fri, 03/10/2023 - 14:49

98

98

PharmExec

MARCH 10, 2023

Global medical affairs teams seek better support to manage relationships with key opinion leaders—and find that balance between patient needs, scientific objectives, and the interest areas of KOLs.

80

80

Fierce Healthcare

MARCH 10, 2023

These are the major challenges hospital executives expect to face this year fdiamond Fri, 03/10/2023 - 15:47

Hospitals 104

Hospitals 104

Drug Store News

MARCH 10, 2023

To launch its new gummies, the brand is debuting a campaign that celebrates PMS through a musical approach.

105

105

Fierce Healthcare

MARCH 10, 2023

Industry Voices—Pharmacists play key role in advancing health equity, pharmacoequity pminemyer Fri, 03/10/2023 - 14:21

98

98

European Pharmaceutical Review

MARCH 10, 2023

A review by researchers on ocular drug delivery discussed strategies that could enhance ocular bioavailability. Currently, effective topical administration is challenging as the industry aims to prolong drug residence time and guarantee appropriate ocular permeation. Although many potent drugs are available to treat most ocular complaints, there are barriers such as tear film, corneal and conjunctival.

Dosage 77

Dosage Compounding 77

Fierce Healthcare

MARCH 10, 2023

Political headwinds grow against CMMI accelerated approval drug price model rking Fri, 03/10/2023 - 16:16

102

102

Drug Store News

MARCH 10, 2023

Within the top five categories in independent pharmacy, 564 new items were reviewed, with nearly 17% awarded Stars.

Independent Pharmacies 98

Independent Pharmacies 98

Fierce Healthcare

MARCH 10, 2023

New female-led, encrypted period tracker app Embody to launch this summer agliadkovskaya Fri, 03/10/2023 - 14:34

98

98

Drug Store News

MARCH 10, 2023

New launches from the brand include Donettes Old Fashioned Mini Donuts and Chocolate Drizzle Baby Bundts.

97

97

Fierce Healthcare

MARCH 10, 2023

Senators urge CMS to close 'loopholes' in payer price transparency rule pminemyer Fri, 03/10/2023 - 16:12

98

98

Drug Store News

MARCH 10, 2023

The opening of the company's first club in Madison, Ala., expands the retailer's footprint to 20 states.

98

98

Drug Topics

MARCH 10, 2023

Your weekly roundup of the latest news from Drug Topics®.

98

98

PharmExec

MARCH 10, 2023

How platforms like ChatGPT could transform engagement models.

119

119